A novel immunotherapy could lead to a brain cancer breakthrough after showing promising results against glioblastoma, the ...
NewYork-Presbyterian's GLICO seeks to overcome glioblastoma's resistance by mimicking brain environments to test treatments ...
A common brain protein may be giving Alzheimer’s disease an unexpected way to spread, carrying toxic Tau proteins from ...
In mice, a brain protein called Arc helps spread toxic molecules from sick brain cells to healthy ones. If therapies could be ...
A newly identified molecule called OLE helped restore the brain’s immune cells to a more protective state in Alzheimer’s ...
What previously required months or years of specialised lab work can now be done in hours or days thanks to its integrated ...
A type of immunotherapy has shown promising results in targeting the deadliest type of brain cancer, researchers say.
An international research team led jointly by the University Medical Center Göttingen (UMG), the University of Göttingen and ...
A study led by a researcher based at King's College London and McMaster University in Canada reveals how CAR-T cell therapy, a treatment that engineers a patient's own immune cells to recognize and ...
A collaborative study led by Professor Vittoria Raffa at the University of Pisa and Assistant Professor Fabian Raudzus (Department of Clinical Application) has unveiled a novel approach that uses ...
Alzheimer's disease is driven by a buildup of a toxic protein called Tau that kills neurons. As toxic Tau spreads to new ...
A Tibetan Plateau study suggests the brain shifts its activity patterns as the body adjusts to low oxygen at high altitude.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results